Skip to search formSkip to main contentSkip to account menu

ramatroban

Known as: 3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazole propanoic acid, 9H-Carbazole-9-propanoic acid, 3-(((4-fluorophenyl)sulfonyl)amino)-1,2,3,4-tetrahydro-, (R)- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Prostaglandin D2(PGD2) plays a key role in many of the physiological markings of allergic inflammation including vasodilation… 
2006
2006
We evaluated the efficacy of early treatment by ramatroban and antihistamine in patients with Japanese cedar pollinosis by… 
2005
2005
(Background) Ramatroban, which is a thromboxane A2 receptor antagonist, has been demonstrated to improve nasal obstruction… 
2002
2002
The clinical efficacy of ramatroban, a thromboxane A2 receptor antagonist, was investigated in 48 patients who consulted Masutani… 
1998
1998
In some clinical studies performed in patients with perennial allergic rhinitis, ramatroban, a new thromboxane A2 receptor… 
1998
1998
Application of population pharmacokinetics (PPK) has become popular during drug development, because of its usefulness 1, 2) as… 
1997
1997
The population pharmacokinetics (population PK) of ramatroban, a new thromboxane A2 receptor antagonist, was studied in 280… 
1997
1997
The present invention relates to a thermodynamically stable modification of the active compound ramatroban of formula (I). The…